1. Home
  2. KWR vs TMDX Comparison

KWR vs TMDX Comparison

Compare KWR & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KWR

Quaker Houghton

HOLD

Current Price

$151.15

Market Cap

2.8B

Sector

Industrials

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$73.64

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KWR
TMDX
Founded
1918
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.5B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
KWR
TMDX
Price
$151.15
$73.64
Analyst Decision
Strong Buy
Buy
Analyst Count
3
9
Target Price
$167.00
$148.22
AVG Volume (30 Days)
141.5K
969.8K
Earning Date
04-30-2026
05-05-2026
Dividend Yield
1.52%
N/A
EPS Growth
N/A
382.18
EPS
1.13
0.20
Revenue
$1,888,634,000.00
$605,494,000.00
Revenue This Year
$5.16
$24.25
Revenue Next Year
$3.63
$18.75
P/E Ratio
$131.70
$355.65
Revenue Growth
2.66
37.13
52 Week Low
$111.42
$60.11
52 Week High
$183.01
$156.00

Technical Indicators

Market Signals
Indicator
KWR
TMDX
Relative Strength Index (RSI) 51.24 47.33
Support Level $146.59 $64.87
Resistance Level $155.88 $79.60
Average True Range (ATR) 5.32 3.13
MACD -0.58 0.02
Stochastic Oscillator 63.41 34.57

Price Performance

Historical Comparison
KWR
TMDX

About KWR Quaker Houghton

Quaker Houghton manufactures and sells a variety of industrial process fluids. The company's product portfolio includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals. The company's geographic segments include the Americas, EMEA, and Asia/Pacific. The majority of the company's revenue is earned from the Americas.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: